The fetal bovine serum market is estimated to be valued at USD 2.12 Bn in 2025 and is expected to reach USD 5.24 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 13.8% from 2025 to 2032.
To learn more about this report, Request sample copy
Fetal bovine serum is extensively utilized in biomedical research, cell culture, biotechnology, and pharmaceuticals as a growth supplement to support cell proliferation until confluence. Key drivers for its use include its rich nutrient profile, which provides essential growth factors, hormones, and proteins necessary for optimal cell growth. However, challenges such as ethical concerns regarding animal welfare and the rising costs of fetal bovine serum (FBS) due to limited supply can restrain its availability.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients